Breast cancer-associated protein--a novel binding partner of Mason-Pfizer monkey virus protease

Area of Science:

• Virology
• Molecular Biology
• Oncology

Background:

• Mason-Pfizer monkey virus (MPMV) is a retrovirus with a protease (PR) essential for its replication cycle.
• Understanding viral protein interactions is crucial for developing antiviral strategies.

Purpose of the Study:

• To identify novel binding partners of MPMV protease.
• To investigate the role of these interactions in viral replication and infectivity.

Main Methods:

• Co-immunoprecipitation assays to confirm protein-protein interactions.
• Immunocolocalization to determine the cellular localization of interacting proteins.
• Analysis of viral particle incorporation and infectivity.

Main Results:

• Breast cancer-associated protein (BCA3) was identified as a novel binding partner of MPMV protease.
• The interaction between MPMV protease and BCA3 was confirmed experimentally.
• Full-length BCA3, but not a C-terminally truncated version, was incorporated into MPMV virions.
• The G-patch domain of MPMV protease was not involved in BCA3 interaction or virion incorporation.
• BCA3 expression did not affect viral particle release or processing but slightly increased MPMV infectivity.

Conclusions:

• BCA3 is a novel binding partner of MPMV protease.
• BCA3 incorporation into virions is dependent on its full-length structure.
• BCA3 may play a role in enhancing MPMV infectivity.